Summary:
- This article discusses new documents that raise questions about the approval process for the Pfizer-BioNTech COVID-19 vaccine.
- The documents suggest that the Centers for Disease Control and Prevention (CDC) may have rushed the approval process and downplayed potential side effects.
- The article highlights the importance of transparency and thorough scientific review in the vaccine approval process, especially during a global pandemic.